Category:
Chiral Intermediates
CAS NO:
/
Standard:
In-house Standards,
/
HCV Protease Inhibitors are small-molecule therapeutics targeting NS3/4A serine protease to block Hepatitis C Virus replication. Synthesized via chiral catalysis, they typically feature a ketoamide warhead with the general formula CxHyNzOw (CAS No. varies by specific agent).
Strictly avoid use in severe hepatic impairment without specialist oversight. Store under inert atmosphere at 2-8°C to maintain chemical stability and prevent hydrolysis of the active moiety.